| 000 | 01508 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511193508.0 | ||
| 264 | 0 | _c19920626 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/s0959-8049(05)80081-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWillemse, P H | |
| 245 | 0 | 0 |
_aA phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c1992 |
||
| 300 |
_a479-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Parenteral |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 700 | 1 | _aSleijfer, D T | |
| 700 | 1 | _ade Vries, E G | |
| 700 | 1 | _aBoonstra, H | |
| 700 | 1 | _aBouma, J | |
| 700 | 1 | _aMulder, N H | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 28 _gno. 2-3 _gp. 479-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0959-8049(05)80081-4 _zAvailable from publisher's website |
| 999 |
_c1597550 _d1597550 |
||